While aging, genetic and biochemical factors influence the formation of intracerebral βA and tau aggregates that constitute core AD-NC criteria, the bases for cognitive decline in persons with AD dementia are variable and complex. The gene discussed is MAPT; the disease is Alzheimer disease.